Alimentiv Inc. Announces New Scientific Advisors Leading Research In GI-Related Therapeutics
LONDON, ON, Oct. 13, 2023 /PRNewswire/ -- Alimentiv Inc. ("Alimentiv"), a leading Contract Research Organization focused on GI-related therapeutics, is pleased to announce the addition of new scientific advisors to its scientific advisory board.
- LONDON, ON, Oct. 13, 2023 /PRNewswire/ -- Alimentiv Inc. ("Alimentiv"), a leading Contract Research Organization focused on GI-related therapeutics, is pleased to announce the addition of new scientific advisors to its scientific advisory board.
- The advisors are internationally recognized experts in designing and conducting clinical research in Inflammatory Bowel Disease.
- Their contributions to the field have been essential in progressing the development of novel therapies in IBD and improving patient outcomes.
- He holds the Crohn's Colitis Canada Endowed Research Chair in Inflammatory Bowel Disease and is an executive member of the IOIBD.